Lytix Biopharma, Vaccibody and Regencis selected for the venture session at DNB Healthcare Conference
The venture session at the DNB Healthcare Conference features three Oslo Cancer Cluster member companies: Lytix Biopharma, Vaccibody and Regencis. They will all present in session five: Therapeutics, that starts at 15:00. See below for the full program.
The venture session is part of the DNB Healthcare Conference on December 2015. In paralell to the venture seesion, there will be presentations of listed companies that features several Oslo Cancer Cluster members as well. See information on this here.
Session one: Medical Devices
Session two: Ultrasound and imaging based medtech companies
Session three: M-Health
Lunch and DNB Health Care Prize
Session four: Diagnostics
Session five: Therapeutics